Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pak Fah Yeow InternationalHKSE:00239 80 Gross Margin % is 84.02% as of Dec. 2025, which is 5% above its 10-year median of 80.32. GuruFocus rates HKSE:00239 with a GF Score™ of 80/100 and a GF Value™ of HK$2.17 (Fairly Valued). The stock has 3 warning signs investors should review. Among 943 Drug Manufacturers companies, Pak Fah Yeow International ranks better than 96.29% on this metric.
HKSE:00239's Gross Margin % is ranked better than 96.29% of 943
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs HKSE:00239: 86.30
Pak Fah Yeow International had a gross margin of 84.02% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Pak Fah Yeow International (HKSE:00239) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Pak Fah Yeow International had a gross margin of 84.02% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Pak Fah Yeow International Gross Margin % Related Terms
Pak Fah Yeow International Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Pak Fah Yeow International's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pak Fah Yeow International Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pak Fah Yeow International's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Pak Fah Yeow International's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Pak Fah Yeow International (HKSE:00239) has a Gross Margin % of 84.02% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Pak Fah Yeow International and its competitors. This is near median its historical median of 80.32. Over the past decade, Pak Fah Yeow International's Gross Margin % has ranged from 76.94 to 86.30. According to the industry distribution chart, Pak Fah Yeow International ranks #35 out of 943 companies in the Drug Manufacturers industry, placing it in the top 3.7%.
Is Pak Fah Yeow International's Gross Margin % too high?
Pak Fah Yeow International's current Gross Margin % of 84.02% is near median its 10-year median of 80.32. Over the past 10 years, this metric has ranged from a low of 76.94 to a high of 86.30. The Drug Manufacturers industry median Gross Margin % is 48.54. Pak Fah Yeow International's value of 84.02% is 73.1% above this industry median. Based on the distribution chart, Pak Fah Yeow International ranks #35 out of 943 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Pak Fah Yeow International has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pak Fah Yeow International's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Pak Fah Yeow International ranks #35 out of 943 companies for Gross Margin %. This places Pak Fah Yeow International in the top 4% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.54. Pak Fah Yeow International's value of 84.02% is 73.1% above this benchmark. Historically, Pak Fah Yeow International's own Gross Margin % has ranged from 76.94 to 86.30 over the past decade. While the company's 10-year median is 80.32 vs. the industry median of 48.54, Pak Fah Yeow International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 943 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pak Fah Yeow International's current Gross Margin % of 84.02% is 73.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Pak Fah Yeow International and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pak Fah Yeow International's current Gross Margin % is 84.02%, which is near median its own 10-year median of 80.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pak Fah Yeow International stock overvalued right now?
Based on GuruFocus' analysis, Pak Fah Yeow International (HKSE:00239) is currently considered Fairly Valued. The stock's GF Value™ is HK$2.17, compared to a current price of HK$2.38 — trading 9.4% above its estimated fair value. The current Gross Margin % is 84.02%, which is near median its 10-year median of 80.32 and 73.1% above the Drug Manufacturers industry median of 48.54. Pak Fah Yeow International's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Pak Fah Yeow International (HKSE:00239), the current Gross Margin % is 84.02% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pak Fah Yeow International (HKSE:00239) Overvalued in 2026?
Based on GuruFocus' analysis, Pak Fah Yeow International stock appears to be overvalued.
The current stock price of HK$2.38 is trading 9.4% above its estimated GF Value™ of HK$2.17.
GuruFocus considers Pak Fah Yeow International to be Fairly Valued.
Key valuation signals for HKSE:00239:
Gross Margin %: 84.02% (near median its 10-year median of 80.32)
GF Value™: HK$2.17 vs. price of HK$2.38 (9.4% above fair value)
Industry Position: 73.1% above the Drug Manufacturers median (#35 of 943)
No single metric tells the full story. See the HKSE:00239 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pak Fah Yeow International Ltd, with its subsidiaries, is engaged in the manufacture and distribution of healthcare products, including Hoe Hin branded products. It also engages in real estate investment and treasury investment businesses. It has three business segments, namely healthcare, property investments, and treasury investments. The Company derives the majority of its revenues from the Healthcare segment.The Groups businesses cover Hong Kong, Macau, other regions in the Peoples Republic of China (the PRC or Chinese Mainland), Southeast Asia, North America and the United Kingdom.
80GF Score
Get the complete analysis for HKSE:00239
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00239 has been successfully added to your 
